BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rafiee P, Stein DJ, Nelson VM, Otterson MF, Shaker R, Binion DG. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol. 2010;298:G167-G176. [PMID: 19926820 DOI: 10.1152/ajpgi.00385.2009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Felipez LM, Gokhale R, Tierney MP, Kirschner BS. Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012;54:28-33. [PMID: 21681114 DOI: 10.1097/mpg.0b013e318228349e] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
2 Wu H, Zhao C, Gu K, Jiao Y, Hao J, Sun G. Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin's lymphoma: A prospective study of 46 cases. Mol Clin Oncol 2014;2:695-700. [PMID: 25054032 DOI: 10.3892/mco.2014.307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Zahran M, Agwa H, Osman A, Hammad S, El-aarag B, Ismail N, Salem T, Gamal-eldeen A. Synthesis and biological evaluation of phthalimide dithiocarbamate and dithioate derivatives as anti-proliferative and anti-angiogenic agents-I. Eur J Chem 2017;8:391-9. [DOI: 10.5155/eurjchem.8.4.391-399.1652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
4 Boers-Sonderen MJ, Mulder SF, Nagtegaal ID, Jacobs JF, Wanten GJ, Hoentjen F, van Herpen CM. Severe exacerbation of Crohn's disease during sunitinib treatment. Eur J Gastroenterol Hepatol 2014;26:234-6. [PMID: 24025975 DOI: 10.1097/MEG.0b013e328365ac54] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Gerich ME, Yoon JL, Targan SR, Ippoliti AF, Vasiliauskas EA. Long-term outcomes of thalidomide in refractory Crohn's disease. Aliment Pharmacol Ther 2015;41:429-37. [PMID: 25511905 DOI: 10.1111/apt.13057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
6 Pourhoseini S, Seth RK, Das S, Dattaroy D, Kadiiska MB, Xie G, Michelotti GA, Nagarkatti M, Diehl AM, Chatterjee S. Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis. PLoS One 2015;10:e0116780. [PMID: 25658689 DOI: 10.1371/journal.pone.0116780] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
7 Badamtseren B, Odkhuu E, Koide N, Haque A, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T. Thalidomide inhibits interferon-γ-mediated nitric oxide production in mouse vascular endothelial cells. Cellular Immunology 2011;270:19-24. [DOI: 10.1016/j.cellimm.2011.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
8 Liu P, Bian Y, Zhong J, Yang Y, Mu X, Liu Z. Establishment and characterization of a rat intestinal microvascular endothelial cell line. Tissue Cell 2021;72:101573. [PMID: 34116500 DOI: 10.1016/j.tice.2021.101573] [Reference Citation Analysis]
9 Hernandez Mde O, Fulco Tde O, Pinheiro RO, Pereira Rde M, Redner P, Sarno EN, Lopes UG, Sampaio EP. Thalidomide modulates Mycobacterium leprae-induced NF-κB pathway and lower cytokine response. Eur J Pharmacol 2011;670:272-9. [PMID: 21925494 DOI: 10.1016/j.ejphar.2011.08.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
10 Kunkler B, Salamango D, DeBruine ZJ, Ploch C, Dean S, Grossens D, Hledin MP, Marquez GA, Madden J, Schnell A, Short M, Burnatowska-Hledin MA. CUL5 is required for thalidomide-dependent inhibition of cellular proliferation. PLoS One 2018;13:e0196760. [PMID: 29746508 DOI: 10.1371/journal.pone.0196760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wang L, Wang S, Xue A, Shi J, Zheng C, Huang Y. Thalidomide Inhibits Angiogenesis via Downregulation of VEGF and Angiopoietin-2 in Crohn's Disease. Inflammation 2021;44:795-807. [PMID: 33206273 DOI: 10.1007/s10753-020-01378-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Martinez-Sanchez J, Palomo M, Torramade-Moix S, Moreno-Castaño AB, Rovira M, Gutiérrez-García G, Fernández-Avilés F, Escolar G, Penack O, Rosiñol L, Carreras E, Diaz-Ricart M. The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium. Bone Marrow Transplant 2020;55:2270-8. [PMID: 32404979 DOI: 10.1038/s41409-020-0947-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Alexander JS, Chaitanya GV, Grisham MB, Boktor M. Emerging roles of lymphatics in inflammatory bowel disease. Ann N Y Acad Sci. 2010;1207 Suppl 1:E75-E85. [PMID: 20961310 DOI: 10.1111/j.1749-6632.2010.05757.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
14 Dong G, Zheng QD, Ma M, Wu SF, Zhang R, Yao RR, Dong YY, Ma H, Gao DM, Ye SL, Cui JF, Ren ZG, Chen RX. Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15. Cancer Med 2018;7:820-30. [PMID: 29383859 DOI: 10.1002/cam4.1330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ichiyama S, Funasaka Y, Yamashita H, Tamura H, Inokuchi K, Saeki H. Leukocytoclastic vasculitis with eosinophilic infiltration associated with thalidomide therapy for multiple myeloma: A case report. Allergology International 2017;66:497-8. [DOI: 10.1016/j.alit.2016.12.006] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Chang X, Zhu Y, Shi C, Stewart AK. Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) 2014;46:240-53. [PMID: 24374776 DOI: 10.1093/abbs/gmt142] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
17 Xie Y, Li D, Luan X, Jin S, Yan B, Tian F. Protective Effect of Thalidomide on 2,4,6-Trinitrobenzenesulfonic Acid-Induced Experimental Colitis in Rats via the Inhibition of T Helper 17 Cells. Can J Gastroenterol Hepatol 2020;2020:8861854. [PMID: 32766176 DOI: 10.1155/2020/8861854] [Reference Citation Analysis]
18 Siamwala JH, Veeriah V, Priya MK, Rajendran S, Saran U, Sinha S, Nagarajan S, Pradeep T, Chatterjee S. Nitric oxide rescues thalidomide mediated teratogenicity. Sci Rep 2012;2:679. [PMID: 22997553 DOI: 10.1038/srep00679] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
19 Theodoratou E, Campbell H, Ventham NT, Kolarich D, Pučić-Baković M, Zoldoš V, Fernandes D, Pemberton IK, Rudan I, Kennedy NA, Wuhrer M, Nimmo E, Annese V, McGovern DP, Satsangi J, Lauc G. The role of glycosylation in IBD. Nat Rev Gastroenterol Hepatol 2014;11:588-600. [PMID: 24912389 DOI: 10.1038/nrgastro.2014.78] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
20 Diamanti A, Capriati T, Papadatou B, Knafelz D, Bracci F, Corsetti T, Elia D, Torre G. The clinical implications of thalidomide in inflammatory bowel diseases. Expert Rev Clin Immunol. 2015;11:699-708. [PMID: 25865355 DOI: 10.1586/1744666x.2015.1027687] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
21 Li TH, Lee PC, Lee KC, Hsieh YC, Tsai CY, Yang YY, Huang SF, Tsai TH, Hsieh SL, Hou MC, Lin HC, Lee SD. Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis. Sci Rep 2016;6:39405. [PMID: 28009008 DOI: 10.1038/srep39405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
22 Cromer WE, Mathis JM, Granger DN, Chaitanya GV, Alexander JS. Role of the endothelium in inflammatory bowel diseases. World J Gastroenterol 2011; 17(5): 578-593 [PMID: 21350707 DOI: 10.3748/wjg.v17.i5.578] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
23 Hui L, Zang K, Wang M, Shang F, Zhang G. Coculture with Clostridium difficile promotes apoptosis of human intestinal microvascular endothelial cells. J Int Med Res 2018;46:4731-9. [PMID: 30392450 DOI: 10.1177/0300060518799267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Dinić J, Efferth T, García-Sosa AT, Grahovac J, Padrón JM, Pajeva I, Rizzolio F, Saponara S, Spengler G, Tsakovska I. Repurposing old drugs to fight multidrug resistant cancers. Drug Resist Updat 2020;52:100713. [PMID: 32615525 DOI: 10.1016/j.drup.2020.100713] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
25 Chen C, Yu CG. Effect of vascular endothelial cells on the pathogenesis of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2013; 21(7): 585-590 [DOI: 10.11569/wcjd.v21.i7.585] [Reference Citation Analysis]
26 Medda R, Lyros O, Schmidt JL, Jovanovic N, Nie L, Link BJ, Otterson MF, Stoner GD, Shaker R, Rafiee P. Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells. Microvasc Res 2015;97:167-80. [PMID: 25446010 DOI: 10.1016/j.mvr.2014.10.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
27 Yang C, Singh P, Singh H, Le ML, El-Matary W. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41:1079-1093. [PMID: 25858208 DOI: 10.1111/apt.13181] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
28 Eckmann L, Neish AS. NF-κB and mucosal homeostasis. Curr Top Microbiol Immunol 2011;349:145-58. [PMID: 20838961 DOI: 10.1007/82_2010_103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]